person

Sebastien O.

Country
France
Department
Rhumatology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
27
Sites with multiple studies

Has run more than one trial at 27 of 60 partner sites.

Specializations

Rheumatoid Arthritis Management

The investigator specializes in advanced therapeutic approaches for rheumatoid arthritis, particularly focusing on patients who have shown inadequate response to targeted treatments. Their research explores the comparative efficacy of subcutaneous biologics in treatment-resistant cases.

  • Biological Response Modifiers
  • Targeted Therapy Optimization
  • Treatment-Resistant RA

Special attention is given to evaluating therapeutic alternatives for patients with complex treatment histories.

Gout Treatment Innovation

The investigator conducts research in gout management, with particular emphasis on treating patients with concurrent kidney conditions. Their work examines innovative therapeutic approaches using interleukin-1 antagonists and traditional treatments.

  • Renal Complications
  • Acute Gout Flares
  • Transplant Patient Care

Focus extends to specialized treatment protocols for patients with chronic kidney disease and transplant recipients.

Treatment Discontinuation Studies

The investigator explores treatment cessation strategies in gout patients who have achieved remission. Their research includes monitoring through ultrasound scanning to evaluate long-term outcomes of therapy discontinuation.

  • Remission Monitoring
  • Therapeutic Withdrawal
  • Long-term Outcomes

Emphasis is placed on identifying optimal conditions for safe treatment discontinuation while maintaining disease control.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.